Back to Search

DAVID RINALDI, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1649241746Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

11146R(LA)

Research & Publications (20)

Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2).
PMID 12393998·Am J Clin Oncol·2002
3-trial
A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma.
PMID 12216095·Cancer·2002
3-trial
A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3).
PMID 11458814·Cancer Invest·2001
3-trial
A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors: Louisiana Oncology Associates protocol no. 1 (LOA-1).
PMID 10683085·Am J Clin Oncol·2000
3-trial
Unexpected absence of correlation between the genetic mechanisms regulating beta-carboline-induced seizures and anxiety manifested in an elevated plus-maze test.
PMID 11682107·Behav Brain Res·2001
4-observational
Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study.
PMID 19543116·J Pediatr Gastroenterol Nutr·2009
4-observational
High sensibility to reactivation by acidic lipids of the recombinant human plasma membrane Ca2+-ATPase isoform 4xb purified from Saccharomyces cerevisiae.
PMID 18822268·Biochim Biophys Acta·2008
8-other
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.
PMID 18728662·Br J Cancer·2008
3-trial
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
PMID 18512224·Cancer·2008
3-trial
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
PMID 18202422·J Clin Oncol·2008
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
4809 AMBASSADOR CAFFERY PKWY, SUITE 110
LAFAYETTE, LA 70508

Quick Facts

NPI
1649241746
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile